You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 145 No. 5, May 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Study
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Dermatologic Disorders, Other
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Distinct Autoimmune Syndromes in Morphea

A Review of 245 Adult and Pediatric Cases

Justin J. Leitenberger, BS; Rachael L. Cayce, BS; Robert W. Haley, MD; Beverley Adams-Huet, MS; Paul R. Bergstresser, MD; Heidi T. Jacobe, MD

Arch Dermatol. 2009;145(5):545-550. doi:10.1001/archdermatol.2009.79

Objective  To determine the prevalence of extracutaneous manifestations and autoimmunity in adult and pediatric patients with morphea.

Design  A retrospective review of 245 patients with morphea.

Setting  University of Texas Southwestern Medical Center–affiliated institutions.

Patients  Patients with clinical findings consistent with morphea.

Main Outcome Measures  Prevalence of concomitant autoimmune diseases, prevalence of familial autoimmune disease, prevalence of extracutaneous manifestations, and laboratory evidence of autoimmunity (antinuclear antibody positivity). Secondary outcome measures included demographic features.

Results  In this group, adults and children were affected nearly equally, and African Americans were affected less frequently than expected. The prevalence of concomitant autoimmunity in the generalized subtype of morphea was statistically significantly greater than that found in all other subtypes combined (P = .01). Frequency of a family history of autoimmune disease showed a trend in favor of generalized and mixed subgroups. The linear subtype showed a significant association with neurologic manifestations, while general systemic manifestations were most common in the generalized subtype. Antinuclear antibody positivity was most frequent in mixed and generalized subtypes.

Conclusions  High prevalences of concomitant and familial autoimmune disease, systemic manifestations, and antinuclear antibody positivity in the generalized and possibly mixed subtypes suggest that these are systemic autoimmune syndromes and not skin-only phenomena. This has implications for the management and treatment of patients with morphea.


Author Affiliations: Departments of Dermatology (Mr Leitenberger, Ms Cayce, and Drs Bergstresser and Jacobe), Internal Medicine (Dr Haley and Ms Adams-Huet), and Clinical Sciences (Drs Haley and Bergstresser and Ms Adams-Huet), The University of Texas Southwestern Medical Center at Dallas.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High Frequency of Genital Lichen Sclerosus in a Prospective Series of 76 Patients With Morphea: Toward a Better Understanding of the Spectrum of Morphea
Lutz et al.
Arch Dermatol 2012;148:24-28.
ABSTRACT | FULL TEXT  

Localized Scleroderma: MR Findings and Clinical Features
Schanz et al.
Radiology 2011;260:817-824.
ABSTRACT | FULL TEXT  

Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma
Klein et al.
Ann Rheum Dis 2011;70:1475-1481.
ABSTRACT | FULL TEXT  

An Evaluation of Long-term Outcomes in Adults With Pediatric-Onset Morphea
Saxton-Daniels and Jacobe
Arch Dermatol 2010;146:1044-1045.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.